Showing results (71-80 of 164) with videos related to
Sort By:
Pageof 17
Gut|June 1, 1995
Characterisation of patients with a complete biochemical response to ursodeoxycholic acidR A Jorgensen, E R Dickson, A F Hofmann, et al.Mayo Clinic Proceedings|June 1, 1978
Plasmaperfusion for the treatment of intractable pruritus of cholestasisB H Lauterburg, A A Pineda, E R Dickson, et al.The Journal of Rheumatology. Supplement|January 1, 1981
The pharmacokinetics of D-penicillamine in manR H Wiesner, E R Dickson, G L Carlson, et al.Hepatology (Baltimore, Md.)|February 1, 1995
Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?K D Lindor, C H Janes, J S Crippin, et al.Hepatology (Baltimore, Md.)|June 1, 1991
Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smokedM J Krowka, P M Grambsch, E S Edell, et al.Hepatology (Baltimore, Md.)|November 1, 1989
Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizabilityP M Grambsch, E R Dickson, M Kaplan, et al.The Journal of Clinical Investigation|June 1, 1995
Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundiceC H Janes, E R Dickson, R Okazaki, et al.Hepatology (Baltimore, Md.)|June 1, 1990
Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosisD R Fregeau, T Prindiville, R L Coppel, et al.Hepatology (Baltimore, Md.)|February 3, 2000
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acidP Angulo, R A Jorgensen, J C Keach, et al.Hepatology (Baltimore, Md.)|March 3, 1999
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosisP Angulo, K P Batts, T M Therneau, et al.Pageof 17